MorphoSys and Heptares Therapeutics signed an agreement to discover novel antibody therapeutics targeting GPCRs. Heptares will generate stabilized receptors (StaRs®) for a set of GPCR disease targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results